Testing a new add-on medication for rheumatoid arthritis

This trial is testing a medication called roflumilast as an add-on to your current rheumatoid arthritis treatment. The medication is designed to reduce inflammation by blocking a protein that triggers joint damage and pain. Researchers want to see if taking this medication alongside your existing therapy helps control your arthritis better than your current treatment alone.

Many people with rheumatoid arthritis don't get enough relief from their current medications, so their disease continues to cause pain and joint damage. This study explores whether this medication could be a helpful addition to standard treatment to give patients better control over their condition.